Current Prevention and Clinical Management of COVID-19 in India

Dharani Abirama Sundari  Shanmugam; Rishi  Choudhury; SB   JAVN; Vinoth Kumar  Ganesan; Magrita  Malngiang; Meenakumari  Sakthivel; Abhijit  Kar; Abishek  Franco; Merugumolu Vijay  Kumar

doi:10.24996/ijs.2024.65.10.7

Authors

Dharani Abirama Sundari Shanmugam Department of Endocrinology, Dr. ALM. PG. Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai – 600 113, Tamil Nadu, INDIA https://orcid.org/0000-0001-6936-0299
Rishi Choudhury Department of Pharmacology, NGSM Institute of Pharmaceutical Sciences, NITTE (Deemed to be University), Mangalore, Karnataka, INDIA
SB JAVN Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur – 603202, Tamil Nadu, INDIA https://orcid.org/0000-0002-9023-4235
Vinoth Kumar Ganesan Department of Medical Research, Dr. V Balaji Diabetes Care and Research Institute, Chennai, INDIA https://orcid.org/0000-0003-3673-6717
Magrita Malngiang Department of Pharmacology, NGSM Institute of Pharmaceutical Sciences, NITTE (Deemed to be University), Mangalore, Karnataka, INDIA
Meenakumari Sakthivel Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur – 603202, Tamil Nadu, INDIA
Abhijit Kar Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur – 603202, Tamil Nadu, INDIA
Abishek Franco Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur – 603202, Tamil Nadu, INDIA.
Merugumolu Vijay Kumar School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Jalandhar, Punjab-144411, INDIA. https://orcid.org/0000-0002-8366-6312

DOI:

https://doi.org/10.24996/ijs.2024.65.10.7

Keywords:

COVID-19, Pandemic, Comorbidities, Vaccines

Abstract

The COVID-19 pandemic has clasped the world by furore storm. India has been the epicenter of the surge in COVID cases since March 2021 which is being considered as the second wave. With every passing week, new guidelines were being implemented by various states as well as the central government to control the situation. Hospitals were running out of beds, oxygen, and medicinal supply with patients with comorbidities suffering the most. A handful of drugs have been approved for direct or emergency use to counter the situation. However, over time some of these drugs have faced strong backlash for being ineffective and hence are no longer in use. In this review, we shall study various vaccines that have been approved in India and abroad and, also various drugs which were approved for treating the COVID-19 patients.